Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study
| Date first appeared online | 16/06/2023 |
| DOI | 10.1136/bmjdrc-2022-003300 |
| Authors | Bain S. |
| Journal Name | BMJ Open Diabetes Research & Care |
| Volume | 11 |
Documents
- 63949.VOR.pdf , Book, © Author(s), 2023. Re-use permitted under CC BY-NC. No commercial re-use.